The effects of polyethylene glycosylated creatine supplementation on muscular strength and power.
The purpose of the present investigation was to examine the effects of 28 days of polyethylene glycosylated creatine (PEG-creatine) supplementation on 1-repetition maximum bench press (1RMBP) and leg extension (1RMLE), mean power (MP), and peak power (PP) from the Wingate Anaerobic test and body weight (BW). This study used a randomized, double-blind, placebo-controlled, parallel design. Twenty-two untrained men (mean age ± SD = 22.1 ± 2.1 years) were randomly assigned to either a Creatine (n = 10) or Placebo (n = 12) group. The Creatine group ingested PEG-creatine (5 g·d), whereas the Placebo group ingested maltodextrin powder (5 g·d). All subjects performed bench press and bilateral leg extension exercises to determine their 1RM values, and 2 consecutive Wingate Anaerobic Tests (separated by 7 minutes) on a cycle ergometer to determine MP and PP before supplementation (day 0) and after 7 (day 7) and 28 (day 28) days of supplementation. The results indicated that there was a significant (p < 0.05) increase in 1RMBP between days 0 and 28 for the Creatine group but not for the Placebo group. There were no significant changes, however, in 1RMLE, MP, PP, or BW for the Creatine or Placebo group. These findings indicated that 28 days of PEG-creatine supplementation without resistance training increased upper body strength but not lower body strength or muscular power. These findings supported the use of the PEG-creatine supplement for increasing 1RMBP strength in untrained individuals.
Department of Nutrition and Health Sciences, Human Performance Laboratory, University of Nebraska-Lincoln, Lincoln, Nebraska, USA. clcamic@unlserve.unl.edu
Clayton L
CL
Camic
C Russell
CR
Hendrix
Terry J
TJ
Housh
Jorge M
JM
Zuniga
Michelle
M
Mielke
Glen O
GO
Johnson
Richard J
RJ
Schmidt
Dona J
DJ
Housh
D000284:Administration, Oral; D000704:Analysis of Variance; D000886:Anthropometry; D003401:Creatine / Q000008:administration & dosage / Q000494:pharmacology*; D019587:Dietary Supplements; D004311:Double-Blind Method; D002149:Energy Intake; D005080:Exercise Test / Q000187:drug effects*; D006801:Humans; D008297:Male; D053580:Muscle Strength / Q000187:drug effects*; D018482:Muscle, Skeletal / Q000187:drug effects*; D010919:Placebos; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000494:pharmacology*; D015203:Reproducibility of Results; D055815:Young Adult
D010919:Placebos; D011092:Polyethylene Glycols; D003401:Creatine